Tandospirone in the Treatment of Generalised Anxiety Disorder and Mixed Anxiety-Depression: Results of a Comparatively High Dosage Trial

Author： Nishitsuji K.  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.24, Iss.2, 2004-01, pp. : 121-126

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pregabalin: In the Treatment of Generalised Anxiety Disorder

By Frampton James E.   Foster Rachel H.  

CNS Drugs, Vol. 20, Iss. 8, 2006-01 ,pp. : 685-693

Adis International

Access to resources Recommend Favorite

Generalised Anxiety Disorder: Treatment Options

By Sramek J.J.  

Drugs, Vol. 62, Iss. 11, 2002-01 ,pp. : 1635-1648

Adis International

Access to resources Recommend Favorite

Paroxetine in the treatment of generalised anxiety disorder

By Snyderman Steven H   Rynn Moira A   Bellew Kevin   Rickels Karl  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 8, 2004-08 ,pp. : 1799-1806

Informa Healthcare

Access to resources Recommend Favorite

Generalised Anxiety Disorder: Guidelines for Diagnosis and Treatment

By Hoehn -Saric R.  

CNS Drugs, Vol. 9, Iss. 2, 1998-02 ,pp. : 85-98

Adis International

Access to resources Recommend Favorite

Pharmacokinetic evaluation of agomelatine for the treatment of generalised anxiety disorder

By Buoli Massimiliano   Mauri Massimo Carlo   Altamura Alfredo Carlo  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 10, Iss. 6, 2014-06 ,pp. : 885-892

Informa Healthcare

Access to resources Recommend Favorite